Thursday, July 20, 2017 2:28:31 PM
•Pluristem may deliver the ONLY drug specifically indicated to treat ARS.
•While Amgen and Sanofi have products that can treat symptoms of ARS, they are used off-label.
•BARDA has spent over $150 million to stockpile off-label treatments, opening the door wide open to an approved PSTI indicated treatment.
https://seekingalpha.com/article/4061827-can-pluristem-therapeutics-corner-acute-radiation-syndrome-market
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM